Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R Chl)Alex F. Herrera,Stephen M. Ansell,Pier Luigi Zinzani,John Radford,Kami J. Maddocks,Antonio Pinto,Graham P. Collins,Veronika Bachanova,Nancy L. Bartlett,Isabelle Bence-Bruckler,Mehdi Hamadani,Justin Kline,Jiri Mayer,Kerry J. Savage,Ranjana H. Advani,Paolo F. Caimi,Rene-Olivier Casasnovas,Tatyana A. Feldman,Brian T. Hess,Mariana Bastos-Oreiro,Sunil Iyengar,Arpad Szomor,William Townsend,Marc Andre, Jerzy Dyczkowski, Sandy Eisen, Andrzej Urban,Serafino Pantano,Hans G. Cruz,Luqiang Wang, Yanina Negievich,Jens Wuerthner,Carmelo Carlo-StellaBLOOD（2022）引用 1|浏览25AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
